Neonatal Bacterial Sepsis

Avery's Diseases of the Newborn (Ninth Edition)

Volumn , Issue , 2012, Pages 538-550

  Ferrieri, Patricia ^a   Wallen, Linda D ^b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875288177     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0134-0.10039-3     Document Type: Chapter

References (127)

1. Amin A., Abdulrazzaq Y.M., Uduman S. Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates. J Infect 2002, 45:42-46.
2. Ancona R.J., Ferrieri P., Williams P.P. Maternal factors that enhance the acquisition of group B-streptococci by newborn infants. J Med Microbiol 1980, 13:273-280.
3. Ansong A.K., Smith P.B., Benjamin D.K., et al. Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Early Hum Dev 2009, 85:S5-S7.
4. Baker C.J., Edwards M.S. Group B streptococcal infections. Infectious diseases of the fetus and newborn infant 1995, 980-1054. WB Saunders, Philadelphia. ed 4. J.S. Remington, J.O. Klein (Eds.).
5. Baker C.J., Edwards M.S. Group B streptococcal conjugate vaccines. Arch Dis Child 2003, 88:375-378.
6. Bender L., Thaarup J., Varming K., et al. Early and late markers for the detection of early-onset neonatal sepsis. Dan Med Bull 2008, 55:219-223.
7. Benitz W.E., Han M.Y., Madan A., et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998, 102:E41.
8. Bernstein H.M., Pollok B.H., Calhoun D.A., et al. Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: a meta-analysis. J Pediatr 2001, 138:917-920.
9. Bizzarro M.J., Raskind C., Baltimore R.S., et al. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005, 116:595-602.
10. Bryan C.S., John J.F., Pai M.S., et al. Gentamicin vs. cefotaxime for therapy of neonatal sepsis. Am J Dis Child 1985, 139:1086-1089.
11. Cairo M.S., Worcester C., Rucker R., et al. Randomized trial of granulocyte transfusion versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr 1992, 120:281-285.
12. Carr R., Modi N., Dore C.J. G-CSF and GM-CSF for treating or preventing neonatal infections (Review). Cochrane Database Syst Rev 2009, 1:CD003066. (edited, no change to conclusions from 3:CD003066, 2003).
13. Castor M.L., Whitney C.G., Como-Sabetti K., et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol 2008, 727505:2008.
14. Centers for Disease Control and Prevention Perinatal group B streptococcal disease after universal screening recommendations: United States, 2003-2005. MMWR Morb Mort Wkly Rep 2007, 56:701-705.
15. Centers for Disease Control and Prevention Trends in perinatal group B streptococcal disease: United States, 2000-2006. MMWR Morb Mort Wkly Rep 2009, 58:109-112.
16. Chen K.T., Puopolo K.M., Eichenwald E.C., et al. No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. Am J Obstet Gynecol 2005, 192:1167-1171.
17. Chirico G., Rondini G., Plebani A., et al. Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. J Pediatr 1987, 110:437-442.
18. Cieslewicz M.J., Chaffin D., Glusman G., et al. Structural and genetic diversity of group B Streptococcus capsular polysaccharides. Infect Immun 2005, 73:3096-3103.
19. Cohen-Wolkowiez M., Moran C., Benjamin D.K., et al. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J 2009, 28:1052-1056.
20. Conway S.P., Ng P.C., Howel D., et al. Prophylactic intravenous immunoglobulin in pre-term infants: a controlled trial. Vox Sang 1990, 59:6-11.
21. Daley A.J., Isaacs D. Australasian Study Group for Neonatal Infections: Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia. Pediatr Infect Dis J 2004, 23:630-634.
22. Diedrick M.J., Flores A.E., Hillier S.L., et al. Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol 2010, 48:3100-3104.
23. DiGeronimo R.J. Lack of efficacy of the urine culture as part of the initial workup of suspected neonatal sepsis. Pediatr Infect Dis J 1992, 11:764-766.
24. Dodge P.R. Neurological sequelae of acute bacterial meningitis. Pediatr Ann 1994, 23:101-106.
25. Dutta S., Narang A., Chakraborty A., et al. Diagnosis of neonatal sepsis using universal primer polymerase chain reaction before and after starting antibiotic drug therapy. Arch Pediatr Adolesc Med 2009, 163:6-11.
26. Dutta S., Reddy R., Sheikh S., et al. Intrapartum antibiotics and risk factors of early onset sepsis. Arch Dis Child Fetal Neonatal Ed 2010, 95:F99-F103.
27. Edgar J.D., Gabriel V., Gallimore J.R., et al. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. BMC Pediatr 2010, 10:22.
28. Edwards M.S., Rench M.A., Haffar A.A., et al. Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr 1985, 106:717-722.
29. Ehl S., Gering B., Bartmann P., et al. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997, 99:216-221.
30. Eickhoff T.C., Klein J.O., Daly A.K., et al. Neonatal sepsis and other infections due to group B beta hemolytic streptococci. N Engl J Med 1964, 27:1221-1228.
31. Ekin I.H., Gurturk K. Characterization of bovine and human group B streptococci isolated in Turkey. J Med Microbiol 2006, 55:517-521.
32. Elliott J.A., Farmer K.D., Facklam R.R. Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol 1998, 36:2115-2116.
33. Escobar G.J., Li D.K., Armstrong M.A., et al. Neonatal sepsis workups in infants ≥2000 grams at birth: a population-based study. Pediatrics 2000, 106:256-263.
34. Evans M.E., Schaffner W., Federspiel C.F., et al. Sensitivity, specificity, and predictive value of body surface cultures in a neonatal intensive care unit. J Am Med Assoc 1988, 259:248-252.
35. Ferrieri P. Neonatal susceptibility and immunity to major bacterial pathogens. Rev Infect Dis 1990, 12:S394-S400.
36. Ferrieri P., Baker S.J., Hillier S.L., et al. Diversity of surface protein expression in group B streptococcal colonizing and invasive isolates. Indian J Med Res 2004, 119:191-196.
37. Ferrieri P., Hillier S.L., Krohn M.A., et al. Characterization of vaginal and rectal colonization with multiple serotypes of group B streptococci using multiple colony picks. Indian J Med Res 2004, 119:208-212.
38. Ferrieri P., Lynfield R., Flores A.E. Invasive disease due to group B Streptococcus serotype IV. Abstracts of the XVII Lancefield International Symposium on Streptococci and Streptococcal Diseases 2008, P 185. Porto Heli, Greece, Abstract, p 284.
39. Foxman B. Contributions of molecular epidemiology to the understanding of infectious disease transmission, pathogenesis, and evolution. Ann Epidemiol 2007, 17:148-156.
40. Garcia-Prats J.A., Cooper R.R., Schneider V.F., et al. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000, 105:523-527.
41. Garges H.P., Mood M.A., Cotton C.M., et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?. Pediatrics 2006, 117:1094-1100.
42. Gerdes J.S. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004, 51:939-959.
43. Gibbs R.S., Castillo M.S., Rodgers P.J. Management of acute chorioamnionitis. Am J Obstet Gynecol 1980, 136:709-713.
44. Greenberg R.G., Smith P.B., Cotton C.M., et al. Traumatic lumbar punctures in neonates: test performance of the cerebrospinal fluid which blood cell count. Pediatr Infect Dis J 2008, 27:1047-1051.
45. Hamada S., Vearncombe M., McGeer A., et al. Neonatal group B streptococcal disease: Incidence, presentation, and mortality. J Matern Fetal Neonatal Med 2008, 21:53-57.
46. Haque K.N., Zaidi M.H., Haque S.K., et al. Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants. Pediatr Infect Dis 1986, 5:622-625.
47. Harrison L.H., Elliott J.A., Dwyer D.M., et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis 1998, 177:998-1002.
48. Henrichsen J., Ferrieri P., Jelinkova J., et al. Nomenclature of antigens of group B streptococci. Int J Syst Bacteriol 1984, 34:500.
49. Hickman M.E., Rench M.A., Ferrieri P., et al. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999, 104:203-209.
50. Hristeva L., Bowler I., Booy R., et al. Value of cerebrospinal fluid examination in the diagnosis of meningitis in the newborn. Arch Dis Child 1993, 69:514-517.
51. Jaye D.L., Waites K.B. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997, 16:735-746.
52. Johnson D.R., Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol 1984, 19:506-510.
53. Jordan H.T., Farley M.M., Craig A., et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008, 27:1057-1064.
54. Kalstone C. Successful antepartum treatment of listeriosis. Am J Obstet Gynecol 1991, 164:57-58.
55. Kasper D.L., Paoletti L.C., Wessels M.R., et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996, 98:2308-2314.
56. Koenig J.M., Keenan W.J. Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin North Am 2009, 56:689-708.
57. Krohn M.A., Hillier S.L., Nugent R.P., et al. The genital flora of women with intraamniotic infection. J Infect Dis 1995, 171:1475-1480.
58. Lam H.S., Ng P.C. Biochemical markers of neonatal sepsis. Pathology 2008, 40:141-148.
59. Larsen J.W., Sever J.L. Group B Streptococcus and pregnancy: a review. Am J Obstet Gynecol 2008, 198:440-448.
60. Levent F., Baker C.J., Rench M.A., et al. Early outcomes of group B Streptococcal meningitis in the 21st century. Pediatr Infect Dis J 2010, 29:1009-1012.
61. Lindahl G., Stålhammar-Carlemalm M., Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 2005, 18:102-127.
62. Lipsitch M. Bacterial vaccines and serotype replacement lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 1999, 5:336-345.
63. Maione D., Margarit I., Rinaudo C.D., et al. Identification of a universal group B Streptococcus vaccine by multiple genome screen. Science 2005, 309:148-150.
64. Makhoul I.R., Sprecher H., Sawaid R., et al. Early-onset group B Streptococcus sepsis in high risk neonates born after prolonged rupture of membranes. Isr Med Assoc J 2009, 11:34-38.
65. Manroe B.L., Weinberg A.G., Rosenfeld C.R., et al. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979, 95:89-98.
66. Mehr S., Doyle L.W. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J 2000, 19:879-887.
67. Mhanna M.J., Alesseh H., Gori A., et al. Cerebrospinal fluid values in very low birth weight infants with suspected sepsis at different ages. Pediatr Crit Care Med 2008, 9:294-298.
68. Mouzinho A., Rosenfeld C.R., Sanchez P.J., et al. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics 1994, 94:76-82.
69. Moyo S.R., Maeland J.A., Bergh K. Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe. J Med Microbiol 2002, 51:595-600.
70. Mulder C.J., van Alphen L., Zanen H.C. Neonatal meningitis caused by Escherichia coli in the Netherlands. J Infect Dis 1984, 150:935-940.
71. Nandyal R.R. Update on group B streptococcal infections: perinatal and neonatal periods. J Perinat Neonatal Nurs 2008, 22:230-237.
72. Newton E.R., Prihoda T.J., Gibbs R.S. Logistic regression analysis of risk factors for intra-amniotic infection. Obstet Gynecol 1989, 73:571-575.
73. Ohlsson A., Lacy J. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 2010, 3:CD001239. (Update of Cochrane Database Syst Rev 1:CD001239, 2004).
74. Ottolini M.C., Lundgren K., Mirkinson L.J., et al. Utility of complete blood count and blood culture screening to diagnoses neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003, 22:430-434.
75. Pankuch G.A., Applebaum P.C., Lorenz R.P., et al. Placental microbiology and histology and the pathogenesis of chorioamnionitis. Obstet Gynecol 1984, 64:802-806.
76. Paoletti L.C., Pinel J., Rodewald A.K., et al. Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice. J Infect Dis 1997, 175:1237-1239.
77. Paoletti L.C., Rench M.A., Kasper D.L., et al. Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines. Infect Immun 2001, 69:6696-6701.
78. Payne N.R., Burke B.A., Day D.L., et al. Correlation of clinical and pathologic findings in early-onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatr Infect Dis 1988, 7:836-847.
79. Philip A.G., Mills P.C. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics 2000, 106:E4.
80. Polk D.B., Steele R.W. Bacterial meningitis progressing with normal cerebrospinal fluid. Pediatr Infect Dis J 1987, 6:1040-1042.
81. Posfay-Barbe K.M., Wald E.R. Listeriosis. Semin Fetal Neonatal Med 2009, 14:228-233.
82. Puopolo K.M., Eichenwald E.C. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010, 125:e1031-1038.
83. Puopolo K.M., Madoff L.C. Type IV neonatal early-onset group B streptococcal disease in a United States hospital. J Clin Microbiol 2007, 45:1360-1362.
84. Schelonka R.L., Yoder B.A., desJardins S.E., et al. Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants. J Pediatr 1994, 125:603-606.
85. Schlech W.F. 3rd: Foodborne listeriosis. Clin Infect Dis 2000, 31:770-775.
86. Schmutz N., Henry E., Jopling J., et al. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol 2008, 28:275-281.
87. Schrag S., Gorwitz R., Fultz-Butts K., et al. Prevention of perinatal group B streptococcal disease. MMWR Recomm Rep 2002, 51:1-22.
88. Schrag S.J., Hadler J.L., Arnold K.E., et al. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 2006, 118:570-576.
89. Schrag S.J., Stoll B.J. Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J 2006, 25:939-940.
90. Schuchat A., Zywicki S.S., Dinsmoor M.J., et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000, 105:21-26.
91. Shah S.S. OhlssonA, ShahVS: Intraventricular antibiotics for bacterial meningitis in neonates. Cochrane Database Syst Rev 2008, 4:. CD004496.
92. Shenoy S., Antony G., Shenoy U.V. Value of superficial cultures in diagnosing neonatal sepsis. Indian J Pediatr 2000, 67:337-338.
93. Shet A., Ferrieri P. Neonatal and maternal group B streptococcal infections: a comprehensive review. Indian J Med Res 2004, 120:141-150.
94. Slotved H.C., Kong F., Lambertsen L., et al. Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol 2007, 45:2929-2936.
95. Smith B.L., Flores A., Dechaine J., et al. Gene encoding the group B streptococcal protein R4, its presence in clinical reference laboratory isolates and R4 protein pepsin sensitivity. Indian J Med Res 2004, 119:213-220.
96. Soper D.E., Mayhall C.G., Dalton H.P. Risk factors for intraamniotic infections: a prospective epidemiologic study. Am J Obstet Gynecol 1989, 161:562-566.
97. Stevens J.P., Eames M., Kent A., et al. Long term outcome of neonatal meningitis. Arch Dis Child Fetal Neonatal Ed 2003, 88:F179-F184.
98. Stocker M., Fontana M., el Helou S., et al. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology 2010, 97:165-174.
99. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347:240-247.
100. Tettelin H., Masignani V., Cieslewicz M.J., et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome,". Proc Natl Acad Sci U S A 2005, 102:13950-13955.
101. Unhanand M., Mustafa M.M., McCracken G.H., et al. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J Pediatr 1993, 122:15-21.
102. Vamvakas E.C., Pineda A.A. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apher 1996, 11:1-9.
103. Van Dyke M.K., Phares C.R., Lynfield R., et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009, 360:2626-2636.
104. Vasan U., Lim D.M., Greenstein R.M., et al. Origin of gastric aspirate polymorphonuclear leukocytes in infants born after prolonged rupture of membranes. Pediatrics 1977, 91:69-72.
105. Verani J.R., Schrag S.J. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 2010, 37:375-392.
106. Visser V.E., Hall R.T. Urine culture in the evaluation of suspected neonatal sepsis. Pediatrics 1979, 94:635-638.
107. Weitkamp J.H., Aschner J.L. Diagnostic use of C-reactive protein (CRP) in assessment of neonatal sepsis. NeoReviews 2005, 6:c508.
108. Wiswell T.E., Baumgart S., Gannon C.M., et al. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed?. Pediatrics 1995, 95:803-806.
109. Wynn J.L., Neu J., Moldawer L.L., et al. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol 2009, 29:79-88.
110. Wynn J.L., Seed P.C., Cotton C.M. Does IVIg administration yield improved immune function in very premature neonates?. J Perinatol 2010, 30:635-642.
111. Zaleznik D.F., Rench M.A., Hillier S., et al. Invasive disease due to group B streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis 2000, 30:276-281.
112. Ansong A.K., Smith P.B., Benjamin D.K., et al. Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Early Hum Dev 2009, 85:S5-S7.
113. Bender L., Thaarup J., Varming K., et al. Early and late markers for the detection of early-onset neonatal sepsis. Dan Med Bull 2008, 55:219-223.
114. Castor M.L., Whitney C.G., Como-Sabetti K., et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol 2008, 727505:2008.
115. Centers for Disease Control and Prevention Trends in perinatal group B streptococcal disease: United States, 2000-2006. MMWR Morb Mort Wkly Rep 2009, 58:109-112.
116. Diedrick M.J., Flores A.E., Hillier S.L., et al. Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol 2010, 48:3100-3104.
117. Edgar J.D., Gabriel V., Gallimore J.R., et al. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. BMC Pediatr 2010, 10:22.
118. Ferrieri P., Baker S.J., Hillier S.L., et al. Diversity of surface protein expression in group B streptococcal colonizing and invasive isolates. Indian J Med Res 2004, 119:191-196.
119. Garges H.P., Mood M.A., Cotton C.M., et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?. Pediatrics 2006, 117:1094-1100.
120. Jordan H.T., Farley M.M., Craig A., et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population based analysis. Pediatr Infect Dis J 2008, 27:1057-1064.
121. Koenig J.M., Keenan W.J. Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin North Am 2009, 56:689-708.
122. Lam H.S., Ng P.C. Biochemical markers of neonatal sepsis. Pathology 2008, 40:141-148.
123. Levent F., Baker C.J., Rench M.A., et al. Early outcomes of group B Streptococcal meningitis in the 21st century. Pediatr Infect Dis J 2010, 29:1009-1012.
124. Puopolo K.M., Eichenwald E.C. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010, 125:e1031-1038.
125. Verani J.R., Schrag S.J. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 2010, 37:375-392.
126. Wynn J.L., Neu J., Moldawer L.L., et al. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol 2009, 29:79-88.
127. Wynn J.L., Seed P.C., Cotton C.M. Does IVIg administration yield improved immune function in very premature neonates?. J Perinatol 2010, 30:635-642.